| 1. | | Recruiting | Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; breast cancer in situ |
| 2. | | Recruiting | Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 3. | | Suspended | BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 4. | | Recruiting | Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ... |
| 5. | | Recruiting | Bortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer |
| 6. | | Completed | Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 7. | | Recruiting | Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Conditions: stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ... |
| 8. | | No longer recruiting | Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 9. | | No longer recruiting | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
Conditions: Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 10. | | No longer recruiting | Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: localized malignant mesothelioma |
| 11. | | No longer recruiting | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 12. | | No longer recruiting | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ... |
| 13. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer |
| 14. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Conditions: extensive stage small cell lung cancer; newly diagnosed carcinoma of unknown primary |
| 15. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Conditions: recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 16. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ... |
| 17. | | No longer recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Conditions: stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ... |
| 18. | | Completed | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
Conditions: Lymphoma; Leukemia |
| 19. | | Recruiting | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 20. | | Completed | Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer
Conditions: Cancer of the Breast; Diagnostic Techniques and Procedures |
| 21. | | Recruiting | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate |
| 22. | | Recruiting | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
Conditions: recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer |
| 23. | | Completed | Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; recurrent uterine sarcoma; recurrent adult soft tissue sarcoma; stage IV uterine sarcoma; ... |
| 24. | | No longer recruiting | Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia |
| 25. | | Completed | Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
Conditions: stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer |
| 26. | | Recruiting | Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
Conditions: Colon Cancer; Rectal Cancer |
| 27. | | Recruiting | High-Dose Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Amyloidosis
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis |
| 28. | | Recruiting | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Conditions: stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
| 29. | | Recruiting | Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
Conditions: sexual dysfunction and infertility; sexuality and reproductive issues; adenocarcinoma of the prostate; stage II prostate cancer |
| 30. | | No longer recruiting | Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 31. | | No longer recruiting | Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 32. | | Recruiting | Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: limited stage small cell lung cancer |
| 33. | | No longer recruiting | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
Conditions: Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer |
| 34. | | No longer recruiting | Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
| 35. | | Recruiting | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate |
| 36. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma |
| 37. | | No longer recruiting | Phase I Study of Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 38. | | No longer recruiting | R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas |
| 39. | | No longer recruiting | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer |
| 40. | | No longer recruiting | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Conditions: adenocarcinoma of the rectum; stage III rectal cancer; stage II rectal cancer; Quality of Life |
| 41. | | No longer recruiting | Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer |
| 42. | | Completed | SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma
Condition: refractory plasma cell neoplasm |
| 43. | | No longer recruiting | Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 44. | | Suspended | Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
Conditions: Recurrent Small Cell Lung Cancer; intermediate type small cell lung cancer |
| 45. | | No longer recruiting | Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
| 46. | | Completed | Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme |
| 47. | | Recruiting | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 48. | | Completed | Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; recurrent pancreatic cancer; stage IVA pancreatic cancer; Stage IV rectal cancer; ... |
| 49. | | Suspended | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer |
